New York S 11: Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities

Status: REFERRED TO HEALTH (as of 2026-02-03)

State: New York · Session: 2025-2026 · Bill: S 11

Sponsors: James Skoufis, Lea Webb, Nathalia Fernandez

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S00011 Summary:

BILL NOS00011 

&nbsp

SAME ASSAME AS A00044

&nbsp

SPONSORSKOUFIS

&nbsp

COSPNSRFERNANDEZ, WEBB

&nbsp

MLTSPNSR

&nbsp

Add §2533, amd §266, Pub Health L

&nbsp

Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).

Go to top S00011 Actions:

BILL NOS00011 

&nbsp

01/08/2025REFERRED TO HEALTH

02/04/20251ST REPORT CAL.269

02/05/20252ND REPORT CAL.

02/10/2025ADVANCED TO THIRD READING 

03/03/2025PASSED SENATE

03/03/2025DELIVERED TO ASSEMBLY

03/03/2025referred to health

01/07/2026died in assembly

01/07/2026returned to senate

01/07/2026REFERRED TO HEALTH

01/27/20261ST REPORT CAL.164

01/28/20262ND REPORT CAL.

01/29/2026ADVANCED TO THIRD READING 

02/03/2026PASSED SENATE

02/03/2026DELIVERED TO ASSEMBLY

02/03/2026referred to health

Go to topS00011 Committee&nbspVotes:

Go to topS00011 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS00011 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 11

 2025-2026 Regular Sessions

 IN SENATE

 (Prefiled)

 January 8, 2025
 ___________

 Introduced by Sens. SKOUFIS, WEBB -- read twice and ordered printed, and
 when printed to be committed to the Committee on Health

 AN ACT to amend the public health law, in relation to requiring disclo-
 sure of information concerning non-invasive prenatal screening for
 chromosomal abnormalities

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new section
 2 2533 to read as follows:
 3 § 2533. Disclosure of information concerning non-invasive prenatal
 4 screening for chromosomal abnormalities. 1. For the purposes of this
 5 section, the term "non-invasive prenatal screening" shall mean any non-
 6 invasive prenatal screening or cell free fetal DNA screening used to
 7 ascertain whether a fetus is at risk for certain chromosomal abnor-
 8 malities.
 9 2. Non-invasive prenatal screenings shall be accompanied by a written
 10 notice, provided by the entity which manufactured, supplied, or other-
 11 wise created such test or which advertised performing these prenatal
 12 screening tests, about the use of such test for screening purposes, the
 13 fact that not all high risk occurrences correspond to a positive result,
 14 the fact that not all low risk results correspond to a negative result,
 15 a clear statement indicating that non-invasive prenatal screenings are
 16 intended solely for screening purposes to assess risk of possible fetal
 17 genetic abnormalities and is not intended to be used for diagnostic
 18 purposes to determine whether such abnormalities actually exist and that
 19 any positive result should be followed by confirmatory diagnostic test-
 20 ing, and that additional follow up is recommended for all high risk
 21 screening. Such written notice shall be provided to a patient or a
 22 potential parent: (a) prior to any prenatal test; (b) with such test
 23 results; and (c) with any materials provided by the entity providing

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD00009-01-5

 S. 11 2

 1 or facilitating the prenatal testing. Such written notice shall be
 2 reviewed and approved by the department. Such written notice shall be
 3 plainly worded and prominently displayed in any material presented to a
 4 patient or a potential parent about prenatal testing services.
 5 c. Nothing contained in this section shall be construed to limit a
 6 health care practitioner licensed, certified, or authorized under title
 7 eight of the education law from recommending certain prenatal testing
 8 services according to the practitioner's reasonable and good faith
 9 professional judgment based on the facts of a patient's case.
 10 § 2. Section 266 of the public health law

View New York S 11 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.